On 29 April 2025, the Annual General Meeting of Nokia Corporation resolved that approximately 40% of the annual fee of the Board members be paid in Nokia shares. In accordance with this resolution, the following shares have been purchased for and on behalf of the Board member. Nokia Corporation Managers' transactions 7 May 2025 at 18:00 EEST Nokia Corporation - Managers' transactions (McNamara) Transaction notification under Article 19 of EU Market Abuse Regulation. Transaction date: 2025-05-07 Venue: NASDA ...

Group 1 - Nokia Corporation's Annual General Meeting resolved that approximately 40% of the annual fee for Board members will be paid in Nokia shares [1] - Elizabeth Crain, a member of the Board, received 19,624 shares as part of a share-based incentive on May 7, 2025, with a unit price of 0.00 EUR [2] - Nokia is recognized as a B2B technology innovation leader, focusing on creating networks that leverage mobile, fixed, and cloud technologies [3][4] Group 2 - Nokia's high-performance networks are designed to integrate seamlessly into various ecosystems, providing new monetization opportunities for service providers and enterprises [4] - The company emphasizes the importance of secure, reliable, and sustainable networks, which are essential for developing future digital services and applications [4]

Core Points - The company granted performance-related restricted shares under the 2025 Long-Term Incentive Plan (LTIP) on May 1, 2025, which will vest on May 1, 2028, subject to performance conditions [1][2] - The awards to the Chief Executive, Omar Abbosh, and Chief Financial Officer, Sally Johnson, were determined based on the average mid-market closing share price of £11.668 for the five trading days up to April 30, 2025 [2] - The remuneration policy for these awards was approved by shareholders at the 2023 Annual General Meeting [2] Summary of Awards - Omar Abbosh received 394,155 restricted shares, representing 450% of his salary [2] - Sally Johnson received 159,411 restricted shares, representing 300% of her salary [2] - Both awards will be subject to an additional two-year holding period after vesting, extending to May 1, 2030 [1] Remuneration Committee's Authority - The Remuneration Committee has the right to adjust payouts based on underlying financial or non-financial performance, ensuring alignment between shareholder and management interests [3] Notification of Transactions - The transactions for both executives were reported as initial notifications under the UK Market Abuse Regulation [4][5] - The nature of the transactions involved the award of performance-related restricted shares under the LTIP [4][5]

Group 1 - Hiab Corporation is a leading provider of smart and sustainable on-road load-handling solutions, focusing on delivering the best customer experience with engaged personnel and partners [2] - The company operates globally with a network of 3,000 own and partner sales and service locations, enabling delivery to over 100 countries [2] - In 2024, Hiab's continuing operations sales totaled approximately EUR 1.6 billion, and the company employs over 4,000 people [2] Group 2 - A notification was made regarding a transaction by Ritva Sotamaa, a member of the Board/Deputy member, involving the receipt of a share-based incentive [1] - The transaction occurred on May 2, 2025, with a volume of 806 shares at a unit price of 0.00 EUR [1] - The aggregated transaction also reflects a volume of 806 shares with a volume-weighted average price of 0.00 EUR [1]

The Annual General Meeting of Shareholders (the “AGM”) of Orrön Energy AB (“Orrön Energy” or the “Company”) was held today, 5 May 2025. The Company’s and the Group’s income statements and balance sheets for the financial year 2024, were adopted and the members of the Board of Directors and the Chief Executive Officer were discharged from liability for the financial year 2024. The AGM resolved that no dividends should be paid for the financial year 2024 and that the distributable reserves are brought forward ...

KALMAR CORPORATION, MANAGERS' TRANSACTIONS, 5 MAY 2025 AT 1:30 PM (EEST) Kalmar Corporation - Managers' transactions - Hedblom____________________________________________ Person subject to the notification requirementName: Hedblom, MarcusPosition: Member of the Board/Deputy memberIssuer: Kalmar CorporationLEI: 636700Z25ZQXLMZ3CY73 Notification type: INITIAL NOTIFICATIONReference number: 636700Z25ZQXLMZ3CY73_20250502083902_12____________________________________________ Transaction date: 2025-04-30Venue: XHEL ...

KALMAR CORPORATION, MANAGERS' TRANSACTIONS, 5 MAY 2025 AT 1:30 PM (EEST) Kalmar Corporation - Managers' transactions - Kemppi-Vasama____________________________________________ Person subject to the notification requirementName: Kemppi-Vasama, TeresaPosition: Member of the Board/Deputy memberIssuer: Kalmar CorporationLEI: 636700Z25ZQXLMZ3CY73 Notification type: INITIAL NOTIFICATIONReference number: 636700Z25ZQXLMZ3CY73_20250502083902_13____________________________________________ Transaction date: 2025-04-3 ...

Vaisala CorporationManagers’ TransactionsMay 2, 2025, at 2:00 p.m. (EEST) Vaisala Corporation: Managers’ Transactions – Voipio, Ville ____________________________________________ Person subject to the notification requirementName: Voipio, VillePosition: Member of the Board/Deputy memberIssuer: Vaisala OyjLEI: 743700RNDD7KU11HW873 Notification type: INITIAL NOTIFICATIONReference number: 743700RNDD7KU11HW873_20250429172841_73 ____________________________________________ Transaction date: 2025-04-29Venue: XHEL ...

Core Points - The Annual General Meeting (AGM) of Husqvarna AB was held on April 29, 2025, where shareholders could attend physically or via advance voting [1] - The profit and loss statements and balance sheets were adopted, with a dividend of SEK 1.00 per share approved, to be paid in two installments [1] - The Board of Directors' proposal for the composition of the Board was approved, with nine members elected, including new members Claes Boustedt, Marlies Gebetsberger, and Magnus Jarlegren [2] - The total remuneration for the Board was set at SEK 8,490,000, with specific amounts allocated to the Chair and other members [3] - KPMG was elected as the auditor for the period until the next AGM, with fees based on approved invoices [4] - The AGM approved the renewal of remuneration guidelines for Group Management and the Remuneration Report [5] - A performance-based long-term incentive program for 2025 was approved, along with authorization for equity swap arrangements to hedge obligations [6] - The Board was authorized to issue up to approximately 57.6 million new B-shares for acquisitions, with pricing based on market value [7] Company Overview - Husqvarna Group is a global leader in innovative solutions for managing forests, parks, and gardens, as well as cutting equipment and diamond tools for construction and stone industries [9] - The company reported net sales of SEK 48.4 billion in 2024 and employs approximately 12,300 people in 40 countries [9]

Core Viewpoint - Zealand Pharma A/S has announced the implementation of long-term incentive programs for 2025 aimed at aligning the interests of its Board of Directors, Corporate Management, and employees with those of shareholders, while also attracting and retaining top talent [1][2]. Long-term Incentive Program - The long-term incentive program includes the granting of restricted share units (RSUs) and performance share units (PSUs) to various stakeholders within the company [2][10]. - The program is designed to align with selected European and U.S. biotech peers and to drive long-term performance [2]. Board of Directors - A total of 29,169 RSUs have been awarded to Zealand Pharma's Board of Directors, with vesting occurring annually in equal tranches over three years [10][5]. - The maximum number of RSUs granted to any Board member is capped at 8,000, with specific monetary limits based on their roles [6]. - Board members are required to hold RSUs equivalent to 200% of their annual grant value within two years of their election [7]. Corporate Management - Zealand Pharma's Corporate Management has been awarded 96,788 PSUs and 96,788 RSUs, with an estimated fair market value of DKK 82.2 million [10][13]. - The PSUs vest based on predefined performance targets, with potential vesting ranging from 0% to 150% after three years [11][12]. - RSUs for Corporate Management will vest annually in equal tranches over three years [12]. Employee Grants - US employees have been awarded 18,502 RSUs, while employees in Denmark have received 128,519 RSUs, with respective estimated fair market values of DKK 7.9 million and DKK 54.6 million [10][17][20]. - RSUs for US employees and employees in Denmark will vest annually in equal tranches over three years, with conditions tied to continued employment [16][19]. Company Overview - Zealand Pharma A/S is a biotechnology company focused on the discovery and development of peptide-based medicines, with over 10 drug candidates in clinical development [22]. - The company has established partnerships with several major pharmaceutical companies and has a presence in both Denmark and the United States [22][23].